Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1219 |
---|---|
Product Name | Anti-Human IL13 Recombinant Antibody(Lebrikizumab) |
Molecular Name | Lebrikizumab |
Alias | Anti-IL13 Recombinant Antibody, Research Grade Lebrikizumab |
CAS Number | 953400-68-5 |
Target | IL13[Homo sapiens] |
Isotype | IgG4 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IP, IF, Inhib |
Buffer | PBS, pH7.5 |
Background | Lebrikizumab (INN) is a humanized monoclonal antibody and an experimental immunosuppressive drug for the treatment of asthma that cannot be adequately controlled with inhalable glucocorticoids. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |